UniProt ID | KAISO_HUMAN | |
---|---|---|
UniProt AC | Q86T24 | |
Protein Name | Transcriptional regulator Kaiso | |
Gene Name | ZBTB33 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 672 | |
Subcellular Localization | Nucleus . Cytoplasm . Also cytoplasmic in cells grown at high densities. | |
Protein Description | Transcriptional regulator with bimodal DNA-binding specificity. Binds to methylated CpG dinucleotides in the consensus sequence 5'-CGCG-3' and also binds to the non-methylated consensus sequence 5'-CTGCNA-3' also known as the consensus kaiso binding site (KBS). Recruits the N-CoR repressor complex to promote histone deacetylation and the formation of repressive chromatin structures in target gene promoters. May contribute to the repression of target genes of the Wnt signaling pathway. May also activate transcription of a subset of target genes by the recruitment of CTNND2. Represses expression of MMP7 in conjunction with transcriptional corepressors CBFA2T3, CBFA2T2 and RUNX1T1. [PubMed: 23251453] | |
Protein Sequence | MESRKLISATDIQYSGSLLNSLNEQRGHGLFCDVTVIVEDRKFRAHKNILSASSTYFHQLFSVAGQVVELSFIRAEIFAEILNYIYSSKIVRVRSDLLDELIKSGQLLGVKFIAELGVPLSQVKSISGTAQDGNTEPLPPDSGDKNLVIQKSKDEAQDNGATIMPIITESFSLSAEDYEMKKIIVTDSDDDDDDVIFCSEILPTKETLPSNNTVAQVQSNPGPVAISDVAPSASNNSPPLTNITPTQKLPTPVNQATLSQTQGSEKLLVSSAPTHLTPNIILLNQTPLSTPPNVSSSLPNHMPSSINLLVQNQQTPNSAILTGNKANEEEEEEIIDDDDDTISSSPDSAVSNTSLVPQADTSQNTSFDGSLIQKMQIPTLLQEPLSNSLKISDIITRNTNDPGVGSKHLMEGQKIITLDTATEIEGLSTGCKVYANIGEDTYDIVIPVKDDPDEGEARLENEIPKTSGSEMANKRMKVKHDDHYELIVDGRVYYICIVCKRSYVCLTSLRRHFNIHSWEKKYPCRYCEKVFPLAEYRTKHEIHHTGERRYQCLACGKSFINYQFMSSHIKSVHSQDPSGDSKLYRLHPCRSLQIRQYAYLSDRSSTIPAMKDDGIGYKVDTGKEPPVGTTTSTQNKPMTWEDIFIQQENDSIFKQNVTDGSTEFEFIIPESY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Sumoylation | ---MESRKLISATDI ---CCCCCEEECCCC | 60.49 | - | |
5 | Sumoylation | ---MESRKLISATDI ---CCCCCEEECCCC | 60.49 | - | |
5 | Ubiquitination | ---MESRKLISATDI ---CCCCCEEECCCC | 60.49 | - | |
8 | Phosphorylation | MESRKLISATDIQYS CCCCCEEECCCCEEC | 35.24 | 29978859 | |
10 | Phosphorylation | SRKLISATDIQYSGS CCCEEECCCCEECHH | 27.18 | 29978859 | |
14 | Phosphorylation | ISATDIQYSGSLLNS EECCCCEECHHHHHH | 18.48 | 29978859 | |
15 | Phosphorylation | SATDIQYSGSLLNSL ECCCCEECHHHHHHH | 12.91 | 29978859 | |
17 | Phosphorylation | TDIQYSGSLLNSLNE CCCEECHHHHHHHHH | 24.60 | 29978859 | |
21 | Phosphorylation | YSGSLLNSLNEQRGH ECHHHHHHHHHHCCC | 32.32 | 29978859 | |
84 | Phosphorylation | IFAEILNYIYSSKIV HHHHHHHHHHCCCCE | 9.59 | 23401153 | |
87 | Phosphorylation | EILNYIYSSKIVRVR HHHHHHHCCCCEEHH | 18.65 | 23401153 | |
103 | Ubiquitination | DLLDELIKSGQLLGV HHHHHHHHHCCCCCC | 62.25 | 21906983 | |
124 | Ubiquitination | GVPLSQVKSISGTAQ CCCHHHEEEEECCCC | 34.14 | 21906983 | |
145 | Acetylation | LPPDSGDKNLVIQKS CCCCCCCCCEEEEEC | 56.56 | 26051181 | |
145 | Ubiquitination | LPPDSGDKNLVIQKS CCCCCCCCCEEEEEC | 56.56 | 29967540 | |
151 | Sumoylation | DKNLVIQKSKDEAQD CCCEEEEECHHHHHH | 48.63 | - | |
151 | Sumoylation | DKNLVIQKSKDEAQD CCCEEEEECHHHHHH | 48.63 | 28112733 | |
151 | Ubiquitination | DKNLVIQKSKDEAQD CCCEEEEECHHHHHH | 48.63 | 22817900 | |
153 | Sumoylation | NLVIQKSKDEAQDNG CEEEEECHHHHHHCC | 67.63 | 28112733 | |
153 | Ubiquitination | NLVIQKSKDEAQDNG CEEEEECHHHHHHCC | 67.63 | 21906983 | |
186 | Phosphorylation | EMKKIIVTDSDDDDD CCCEEEECCCCCCCC | 21.27 | 30266825 | |
188 | Phosphorylation | KKIIVTDSDDDDDDV CEEEECCCCCCCCCE | 33.31 | 26657352 | |
199 | Phosphorylation | DDDVIFCSEILPTKE CCCEEEEECCCCCCC | 19.54 | 27251275 | |
204 | Phosphorylation | FCSEILPTKETLPSN EEECCCCCCCCCCCC | 37.76 | 27251275 | |
207 | Phosphorylation | EILPTKETLPSNNTV CCCCCCCCCCCCCCE | 45.59 | 26074081 | |
210 | Phosphorylation | PTKETLPSNNTVAQV CCCCCCCCCCCEEEE | 45.91 | 26074081 | |
213 | Phosphorylation | ETLPSNNTVAQVQSN CCCCCCCCEEEECCC | 22.82 | 26074081 | |
219 | Phosphorylation | NTVAQVQSNPGPVAI CCEEEECCCCCCEEE | 46.25 | 30108239 | |
227 | Phosphorylation | NPGPVAISDVAPSAS CCCCEEEEECCCCCC | 19.12 | 30108239 | |
232 | Phosphorylation | AISDVAPSASNNSPP EEEECCCCCCCCCCC | 34.29 | 30108239 | |
234 | Phosphorylation | SDVAPSASNNSPPLT EECCCCCCCCCCCCC | 40.66 | 30108239 | |
237 | Phosphorylation | APSASNNSPPLTNIT CCCCCCCCCCCCCCC | 31.95 | 25159151 | |
241 | Phosphorylation | SNNSPPLTNITPTQK CCCCCCCCCCCCCCC | 30.28 | 30108239 | |
244 | Phosphorylation | SPPLTNITPTQKLPT CCCCCCCCCCCCCCC | 23.50 | 30108239 | |
246 | Phosphorylation | PLTNITPTQKLPTPV CCCCCCCCCCCCCCC | 29.68 | 25850435 | |
251 | Phosphorylation | TPTQKLPTPVNQATL CCCCCCCCCCCCCCH | 50.75 | 15548582 | |
257 | O-linked_Glycosylation | PTPVNQATLSQTQGS CCCCCCCCHHCCCCC | 19.71 | 30379171 | |
257 | Phosphorylation | PTPVNQATLSQTQGS CCCCCCCCHHCCCCC | 19.71 | 30576142 | |
259 | Phosphorylation | PVNQATLSQTQGSEK CCCCCCHHCCCCCCE | 27.16 | 25159151 | |
264 | Phosphorylation | TLSQTQGSEKLLVSS CHHCCCCCCEEEEEC | 23.03 | 25159151 | |
379 | Phosphorylation | IQKMQIPTLLQEPLS HHHCCCCHHHHCCCC | 41.55 | 22210691 | |
386 | Phosphorylation | TLLQEPLSNSLKISD HHHHCCCCCCCCHHH | 34.78 | 28348404 | |
388 | Phosphorylation | LQEPLSNSLKISDII HHCCCCCCCCHHHHH | 27.88 | 28348404 | |
390 | Sumoylation | EPLSNSLKISDIITR CCCCCCCCHHHHHCC | 39.73 | 28112733 | |
406 | Phosphorylation | TNDPGVGSKHLMEGQ CCCCCCCCHHHHCCC | 17.94 | 26714015 | |
407 | Sumoylation | NDPGVGSKHLMEGQK CCCCCCCHHHHCCCE | 34.52 | - | |
407 | Acetylation | NDPGVGSKHLMEGQK CCCCCCCHHHHCCCE | 34.52 | 26051181 | |
407 | Sumoylation | NDPGVGSKHLMEGQK CCCCCCCHHHHCCCE | 34.52 | 28112733 | |
407 | Ubiquitination | NDPGVGSKHLMEGQK CCCCCCCHHHHCCCE | 34.52 | 21963094 | |
414 | Sumoylation | KHLMEGQKIITLDTA HHHHCCCEEEEECCC | 47.10 | 28112733 | |
414 | Ubiquitination | KHLMEGQKIITLDTA HHHHCCCEEEEECCC | 47.10 | - | |
428 | Phosphorylation | ATEIEGLSTGCKVYA CHHHCCCCCCCEEEE | 33.34 | - | |
434 | Phosphorylation | LSTGCKVYANIGEDT CCCCCEEEEECCCCE | 4.57 | 27642862 | |
441 | Phosphorylation | YANIGEDTYDIVIPV EEECCCCEEEEEEEE | 20.84 | 28796482 | |
442 | Phosphorylation | ANIGEDTYDIVIPVK EECCCCEEEEEEEEC | 18.92 | 28796482 | |
449 | Sumoylation | YDIVIPVKDDPDEGE EEEEEEECCCCCCCH | 51.57 | - | |
449 | Sumoylation | YDIVIPVKDDPDEGE EEEEEEECCCCCCCH | 51.57 | 28112733 | |
449 | Ubiquitination | YDIVIPVKDDPDEGE EEEEEEECCCCCCCH | 51.57 | 29967540 | |
465 | Sumoylation | RLENEIPKTSGSEMA HHHCCCCCCCCHHHH | 62.07 | 28112733 | |
465 | Ubiquitination | RLENEIPKTSGSEMA HHHCCCCCCCCHHHH | 62.07 | 29967540 | |
474 | Sumoylation | SGSEMANKRMKVKHD CCHHHHHHCCCCCCC | 44.31 | - | |
474 | Acetylation | SGSEMANKRMKVKHD CCHHHHHHCCCCCCC | 44.31 | 25953088 | |
474 | Sumoylation | SGSEMANKRMKVKHD CCHHHHHHCCCCCCC | 44.31 | 28112733 | |
474 | Ubiquitination | SGSEMANKRMKVKHD CCHHHHHHCCCCCCC | 44.31 | 21906983 | |
475 | Ubiquitination | GSEMANKRMKVKHDD CHHHHHHCCCCCCCC | 29.93 | 21890473 | |
479 | Sumoylation | ANKRMKVKHDDHYEL HHHCCCCCCCCCEEE | 35.48 | - | |
479 | Sumoylation | ANKRMKVKHDDHYEL HHHCCCCCCCCCEEE | 35.48 | 28112733 | |
479 | Ubiquitination | ANKRMKVKHDDHYEL HHHCCCCCCCCCEEE | 35.48 | 33845483 | |
484 | Phosphorylation | KVKHDDHYELIVDGR CCCCCCCEEEEECCE | 21.30 | 20393185 | |
491 | Methylation | YELIVDGRVYYICIV EEEEECCEEEEEEEE | 14.59 | - | |
502 | O-linked_Glycosylation | ICIVCKRSYVCLTSL EEEEECCCEEEHHHH | 13.86 | 30379171 | |
517 | Phosphorylation | RRHFNIHSWEKKYPC HHHCCCCCCCCCCCC | 32.88 | 28555341 | |
521 | Ubiquitination | NIHSWEKKYPCRYCE CCCCCCCCCCCCCCC | 42.80 | - | |
529 | Sumoylation | YPCRYCEKVFPLAEY CCCCCCCHHEEHHHH | 45.69 | - | |
529 | Sumoylation | YPCRYCEKVFPLAEY CCCCCCCHHEEHHHH | 45.69 | - | |
529 | Ubiquitination | YPCRYCEKVFPLAEY CCCCCCCHHEEHHHH | 45.69 | 21987572 | |
530 | Ubiquitination | PCRYCEKVFPLAEYR CCCCCCHHEEHHHHC | 2.52 | 21890473 | |
539 | Sumoylation | PLAEYRTKHEIHHTG EHHHHCCCCCCCCCC | 30.18 | 28112733 | |
539 | Ubiquitination | PLAEYRTKHEIHHTG EHHHHCCCCCCCCCC | 30.18 | 29967540 | |
558 | Phosphorylation | QCLACGKSFINYQFM EEECCCCCHHHHHHH | 19.35 | 21659604 | |
562 | Phosphorylation | CGKSFINYQFMSSHI CCCCHHHHHHHHHHH | 9.79 | 21659604 | |
567 | Phosphorylation | INYQFMSSHIKSVHS HHHHHHHHHHHHHCC | 19.90 | 21659604 | |
570 | Sumoylation | QFMSSHIKSVHSQDP HHHHHHHHHHCCCCC | 40.79 | 28112733 | |
570 | Ubiquitination | QFMSSHIKSVHSQDP HHHHHHHHHHCCCCC | 40.79 | 29967540 | |
571 | Phosphorylation | FMSSHIKSVHSQDPS HHHHHHHHHCCCCCC | 25.18 | 28985074 | |
574 | Phosphorylation | SHIKSVHSQDPSGDS HHHHHHCCCCCCCCC | 33.84 | 29396449 | |
582 | Sumoylation | QDPSGDSKLYRLHPC CCCCCCCCEEEEEEC | 55.03 | - | |
582 | Sumoylation | QDPSGDSKLYRLHPC CCCCCCCCEEEEEEC | 55.03 | 28112733 | |
582 | Ubiquitination | QDPSGDSKLYRLHPC CCCCCCCCEEEEEEC | 55.03 | 21906983 | |
583 | Ubiquitination | DPSGDSKLYRLHPCR CCCCCCCEEEEEECC | 3.31 | 21890473 | |
599 | Phosphorylation | LQIRQYAYLSDRSST EEEEEEEECCCCCCC | 11.21 | 29052541 | |
601 | Phosphorylation | IRQYAYLSDRSSTIP EEEEEECCCCCCCCC | 20.50 | 29052541 | |
604 | Phosphorylation | YAYLSDRSSTIPAMK EEECCCCCCCCCCCC | 36.50 | 29759185 | |
605 | Phosphorylation | AYLSDRSSTIPAMKD EECCCCCCCCCCCCC | 31.11 | 29759185 | |
606 | Phosphorylation | YLSDRSSTIPAMKDD ECCCCCCCCCCCCCC | 32.02 | 29759185 | |
611 | Sumoylation | SSTIPAMKDDGIGYK CCCCCCCCCCCCCEE | 55.57 | - | |
611 | Sumoylation | SSTIPAMKDDGIGYK CCCCCCCCCCCCCEE | 55.57 | 28112733 | |
611 | Ubiquitination | SSTIPAMKDDGIGYK CCCCCCCCCCCCCEE | 55.57 | - | |
618 | Sumoylation | KDDGIGYKVDTGKEP CCCCCCEECCCCCCC | 28.55 | - | |
618 | Sumoylation | KDDGIGYKVDTGKEP CCCCCCEECCCCCCC | 28.55 | 28112733 | |
618 | Ubiquitination | KDDGIGYKVDTGKEP CCCCCCEECCCCCCC | 28.55 | 22817900 | |
623 | Sumoylation | GYKVDTGKEPPVGTT CEECCCCCCCCCCCC | 69.96 | - | |
623 | Ubiquitination | GYKVDTGKEPPVGTT CEECCCCCCCCCCCC | 69.96 | 21963094 | |
624 | Ubiquitination | YKVDTGKEPPVGTTT EECCCCCCCCCCCCC | 57.06 | 21890473 | |
630 | Phosphorylation | KEPPVGTTTSTQNKP CCCCCCCCCCCCCCC | 16.90 | - | |
631 | Phosphorylation | EPPVGTTTSTQNKPM CCCCCCCCCCCCCCC | 29.61 | - | |
636 | Ubiquitination | TTTSTQNKPMTWEDI CCCCCCCCCCCHHHE | 26.75 | 21963094 | |
639 | Phosphorylation | STQNKPMTWEDIFIQ CCCCCCCCHHHEEEE | 33.94 | - | |
651 | Phosphorylation | FIQQENDSIFKQNVT EEEECCCCCEECCCC | 41.32 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of KAISO_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KAISO_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KAISO_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
HDAC3_HUMAN | HDAC3 | physical | 14527417 | |
NCOR1_HUMAN | NCOR1 | physical | 14527417 | |
CTND2_HUMAN | CTNND2 | physical | 21070476 | |
CTCF_HUMAN | CTCF | physical | 16230345 | |
CTND1_HUMAN | CTNND1 | physical | 21670201 | |
CTNB1_HUMAN | CTNNB1 | physical | 21670201 | |
TF7L2_HUMAN | TCF7L2 | physical | 21670201 | |
IMA1_HUMAN | KPNA2 | physical | 15564377 | |
CTND1_HUMAN | CTNND1 | physical | 15564377 | |
P53_HUMAN | TP53 | physical | 25288747 | |
KAT5_HUMAN | KAT5 | physical | 25288747 | |
EP300_HUMAN | EP300 | physical | 25288747 | |
CTND1_HUMAN | CTNND1 | physical | 24498333 | |
FOXM1_HUMAN | FOXM1 | physical | 26496610 | |
SF3B1_HUMAN | SF3B1 | physical | 26496610 | |
CLP1L_HUMAN | CLPTM1L | physical | 26496610 | |
KLF16_HUMAN | KLF16 | physical | 26496610 | |
DPH7_HUMAN | DPH7 | physical | 26496610 | |
TM10A_HUMAN | TRMT10A | physical | 26496610 | |
SGF29_HUMAN | CCDC101 | physical | 26496610 | |
TRIMM_HUMAN | TRIML2 | physical | 26496610 | |
CCD61_HUMAN | CCDC61 | physical | 26496610 | |
P53_HUMAN | TP53 | physical | 26183023 | |
TF65_HUMAN | RELA | physical | 26183023 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-237, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-442, AND MASSSPECTROMETRY. |